We are live on ! Find out more
EGI

EAM Global Investors Portfolio holdings

AUM $47.1M
1-Year Est. Return 320.45%
This Fund
S&P 500
This Quarter Est. Return
+112.7%
1 Year Est. Return
+320.45%
3 Year Est. Return
+2,492.23%
5 Year Est. Return
+19,933.92%
10 Year Est. Return
AUM
$222M
AUM Growth
+$51.5M
Cap. Flow
-$23.5M
Cap. Flow %
-10.58%
Top 10 Hldgs %
17.91%
Holding
167
New
66
Increased
4
Reduced
42
Closed
49

Top Buys

Rank Stock Value
1
AUDC icon
AudioCodes
AUDC
+$5.1M
2
GPRK icon
GeoPark
GPRK
+$3.43M
3
MODV
ModivCare
MODV
+$2.43M
4
AZUL
Azul
AZUL
+$2.31M
5
MTLS
Materialise
MTLS
+$2.2M

Sector Composition

Rank Sector Weight
1 Healthcare 29.98%
2 Technology 20.43%
3 Consumer Discretionary 14.32%
4 Industrials 10.58%
5 Communication Services 3.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUE icon
76
Cue Biopharma
CUE
$114M
$1.46M 0.66%
+1,987
New +$1.44M
ARCT icon
77
Arcturus Therapeutics
ARCT
$211M
$1.45M 0.65%
+30,948
New +$1.07M
INSP icon
78
Inspire Medical Systems
INSP
$1.74B
$1.44M 0.65%
16,545
-11,372
-41% -$874K
LITS
79
Lite Strategy Inc
LITS
$30.9M
$1.43M 0.64%
+17,271
New +$1.05M
RVP icon
80
Retractable Technologies
RVP
$20.1M
$1.39M 0.62%
+197,532
New +$914K
CRNC icon
81
Cerence
CRNC
$413M
$1.39M 0.62%
33,916
-75,620
-69% -$2.17M
MCRI icon
82
Monarch Casino & Resort
MCRI
$2.23B
$1.37M 0.62%
+40,241
New +$1.33M
IDYA icon
83
IDEAYA Biosciences
IDYA
$3.56B
$1.35M 0.61%
+95,106
New +$749K
INFU icon
84
InfuSystem Holdings
INFU
$249M
$1.34M 0.6%
+115,958
New +$1.33M
ICAD
85
DELISTED
iCAD Inc
ICAD
$1.3M 0.58%
129,847
-115,772
-47% -$1.25M
AWH
86
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$1.28M 0.58%
+22,315
New +$1.49M
DRNA
87
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.27M 0.57%
50,151
-38,314
-43% -$825K
ASPU
88
DELISTED
ASPEN GROUP, INC.
ASPU
$1.22M 0.55%
134,847
-99,696
-43% -$820K
KDMN
89
DELISTED
Kadmon Holdings, Inc.
KDMN
$1.2M 0.54%
234,479
-276,534
-54% -$1.24M
UNFI icon
90
United Natural Foods
UNFI
$2.85B
$1.2M 0.54%
+65,909
New +$989K
PAR icon
91
PAR Technology
PAR
$735M
$1.2M 0.54%
39,935
-25,749
-39% -$563K
FORM icon
92
FormFactor
FORM
$9.17B
$1.19M 0.54%
40,601
-9,380
-19% -$231K
MODN
93
DELISTED
MODEL N, INC.
MODN
$1.16M 0.52%
33,424
-24,145
-42% -$703K
CALY
94
Callaway Golf Company
CALY
$3.14B
$1.15M 0.52%
+65,773
New +$914K
CTSO icon
95
Cytosorbents Corp
CTSO
$22.6M
$1.13M 0.51%
114,109
+52,314
+85% +$480K
KALA icon
96
KALA BIO
KALA
$14.5M
$1.11M 0.5%
42
-3
-7% -$85K
AXTI icon
97
AXT Inc
AXTI
$5.8B
$1.1M 0.49%
+230,549
New +$1.09M
PRNB
98
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$1.08M 0.49%
18,061
-25,308
-58% -$1.56M
KOD icon
99
Kodiak Sciences
KOD
$2.84B
$1.08M 0.48%
19,920
-29,736
-60% -$1.68M
PJT icon
100
PJT Partners
PJT
$4.38B
$1.08M 0.48%
+20,954
New +$1.03M

Similar funds

EAM Global Investors's Q2 2020 Portfolio in Review

As of Q2 2020, EAM Global Investors held 167 positions worth $222M, up 30% from $171M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

EAM Global Investors withdrew a net $23.5M in Q2 2020, closing 49 positions and reducing 42 holdings. Its most notable exit was BELLUS Health Inc., an estimated $5.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 41% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, EAM Global Investors opened a new position in AudioCodes worth $5.28M.

  • EAM Global Investors's largest Q2 2020 buy was AudioCodes: 166,008 shares worth $5.28M.
  • EAM Global Investors added most to Purple Innovation in Q2 2020, an estimated $1.17M increase.
  • EAM Global Investors's biggest Q2 2020 reduction was Kornit Digital, cutting an estimated $3.2M.
  • EAM Global Investors fully exited BELLUS Health Inc. in Q2 2020, selling an estimated $5.44M.
  • EAM Global Investors's ten largest holdings make up 18% of its $222M portfolio in Q2 2020.
  • EAM Global Investors opened 66 new positions and closed 49 in Q2 2020.
  • EAM Global Investors's portfolio value rose 30% quarter-over-quarter to $222M.

Based on EAM Global Investors's 13F filing for Q2 2020, filed 13 Aug 2020.